Training & Education

Training & Education

Patient-focused resources, tips from experts, and challenging clinical questions from ASH Clinical News

How to manage bleeding risk in a pregnant patient with factor XI deficiency?

This month, Jean Marie Connors, MD, discusses how to manage the bleeding risk in a pregnant patient with factor XI deficiency. Also check out  next...

What are the prescribing options in the case of anticoagulation failure in deep vein...

This month, Joel S. Bennett, MD, discusses the possibility of novel oral anticoagulant failure in a patient with deep vein thrombosis. And don't forget to...

Research by Design

Educating young scientists to design successful research projects often comes down to teaching them the right questions to ask. A high-quality educational research project begins...

How should this patient with severe macrocytic anemia be managed?

This month, Ruben A. Mesa, MD, discusses treatment options for a 73-year-old male patient with severe macrocytic anemia. Also check out next month's clinical dilemma...

Should I give CHOP-based therapy to a patient with peripheral T-cell lymphoma NOS?

This month, Eric D. Jacobsen, MD, weighs in on administering CHOP-based therapy to a patient diagnosed with peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS). You...

Navigating Clinical Trials

A clinical trial is a controlled research study conducted by doctors and medical researchers to improve the care and treatment of people who have...

How long should a patient continue anticoagulation and should she continue during pregnancy?

This month, Jean Marie Connors, MD, discusses how long a 31-year-old patient should continue anticoagulation and the recommendations for pregnancy.A 31-year-old female, who had...

Women and the Risk of Blood Clots

Nearly 900,000 people are affected by blood clots each year, leading to approximately 100,000 blood clot-related deaths annually. Dangerous blood clots such as deep-vein...

A Commitment to Training and Mentoring

Colleagues and former trainees describe Dr. Boxer’s career and his passion for mentoring. Dr. Boxer is the winner of the 2016 ASH Clinical Investigation...

Would you restart rituximab as part of a new chemotherapy regimen for this patient...

This month, Arnold S. Freedman, MD, answers a question about restarting rituximab as part of a new chemotherapy regimen for a patient with diffuse...
Advertisement

Current Issue

May 2017, Volume 3, Issue 6

This issue discusses the legacy of Agent Orange and hematologic malignancies, a debate over transplant in myelodysplastic syndromes, and more.